Atenolol and Chlorthalidone NDC 68788-4156

NDC codes

FDA NDC Directory

Product NDC (as listed)68788-4156Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68788-4156Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68788-4156-1	68788415601	100 TABLET in 1 BOTTLE (68788-4156-1)Marketed from Jul 16, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Atenolol and Chlorthalidone
Generic name (nonproprietary): atenolol and chlorthalidone
Active ingredients: Atenolol — 100 mg/1Chlorthalidone — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Preferred Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213302
Marketing start: Jul 16, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)Increased Diuresis (Physiologic effect)
Identifiers: Product ID 68788-4156_c58e12ad-d705-4643-91ac-ff079e9eb28eSPL ID c58e12ad-d705-4643-91ac-ff079e9eb28eSPL set ID c58e12ad-d705-4643-91ac-ff079e9eb28eRxCUI 197382UNII 50VV3VW0TI, Q0MQD1073Q
Pharmacologic class: Thiazide-like Diuretic; beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788415601 followed by a unit qualifier and the quantity

Package 68788-4156-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 16, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Atenolol and chlorthalidone tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including atenolol and chlorthalidone. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213302

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213302
Product	Strength	Form · route	Labeler	Product NDC
Atenolol and Chlorthalidone	Atenolol 50 mg/1; Chlorthalidone 25 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-400
Atenolol and Chlorthalidone	Atenolol 100 mg/1; Chlorthalidone 25 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-401
Atenolol and Chlorthalidone	Atenolol 100 mg/1; Chlorthalidone 25 mg/1	TabletOral	REMEDYREPACK INC.	70518-4111